Prior notification of a concentration (Case M.11919 – PURE HEALTH HOLDING / HELLENIC HEALTHCARE) – Candidate case for simplified procedure
Date: 2025-03-05
Institutions: Directorate-General for Competition, European Commission
Subjects: Cyprus, Greece, United Arab Emirates, United Kingdom, economic concentration, health care, medical device, medical institution, merger control, provision of services








C_202501503EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/1503


5.3.2025






Prior notification of a concentration
(Case M.11919 – PURE HEALTH HOLDING / HELLENIC HEALTHCARE)
Candidate case for simplified procedure
(Text with EEA relevance)
(C/2025/1503)


1.   
On 24 February 2025, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Pure Health Holding PJSC (‘Pure Health’, United Arab Emirates), controlled by Abu Dhabi Developmental Holding Company PJSC (‘ADQ’, United Arab Emirates).










—


Hellenic Healthcare S.à.r.l. (‘Hellenic Healthcare’, Luxembourg).




Pure Health will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Hellenic Healthcare.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are the following:






—


Pure Health operates hospitals, clinics and laboratories and provides hospital related services. Pure Health is primarily active in the UAE, and has an international presence in the UK, where it operates a network of 50 hospitals through Circle Health Group,










—


Hellenic Healthcare is a private healthcare group operating hospitals and medical centres in Greece and Cyprus. It is also active in procuring and trading with medical devices and consumables and providing occupational safety and healthcare services.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified treatment for certain concentrations under Council Regulation (EC) No 139/2004 on the control of concentrations between undertakings (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed concentration to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11919 – PURE HEALTH HOLDING / HELLENIC HEALTHCARE
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu

Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  
            OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  
            OJ C 160, 5.5.2023, p. 1.


ELI: http://data.europa.eu/eli/C/2025/1503/oj
ISSN 1977-091X (electronic edition)